Literature DB >> 12412982

Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.

Hiroaki Momi1, Wataru Matsuyama, Koji Inoue, Masaharu Kawabata, Kimiyoshi Arimura, Hidetomo Fukunaga, Mitsuhiro Osame.   

Abstract

To evaluate the predictive value of vascular endothelial growth factor (VEGF) in the differential diagnosis of pleuritis and its association with other proinflammatory cytokines in pleural effusion, we measured VEGF together with interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha) and soluble intercellular adhesion molecule-1 (sICAM-1) in pleural effusions. We investigated 127 patients with pleural effusion (congestive heart failure: 21; parapneumonic: 27; tuberculous: 41; malignant: 38). We examined standard parameters of pleural effusion and measured pleural effusion VEGF, IL-1beta, TNF-alpha and sICAM-1 using enzyme-linked immunosorbent assay. VEGF level was significantly higher in malignant effusion than in other groups. TNF-alpha level was significantly higher in tuberculous pleurisy than in other groups. In tuberculous pleurisy VEGF level showed significant positive correlations with mononuclear cell counts and all investigated cytokines. The sensitivity and specificity of VEGF in the diagnosis of malignancy was 100 and 84%, respectively (cutoff = 2000 pg/ml). The sensitivity and specificity of VEGF and TNF-alpha in the diagnosis of tuberculous pleurisy (VEGF titer <2000 pg/ml and TNF-alpha titer > 55 pg/ml) was 88.9 and 77.1%, respectively. We propose that measurement of VEGF together with TNF-alpha is helpful in differentiating between tuberculous pleurisy and malignant pleural effusion and that VEGF correlates with proinflammatory cytokines especially in tuberculous pleurisy. We also propose that measurement of pleural VEGF is helpful for the diagnosis of malignant pleural effusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12412982     DOI: 10.1053/rmed.2002.1364

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

1.  Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.

Authors:  Yong-Chun Shen; Meng-Qi Liu; Chun Wan; Lei Chen; Tao Wang; Fu-Qiang Wen
Journal:  Exp Ther Med       Date:  2012-03-14       Impact factor: 2.447

Review 2.  Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.

Authors:  Yiran Niu; Qiong Zhou
Journal:  Cell Mol Life Sci       Date:  2022-03-17       Impact factor: 9.261

3.  Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

4.  Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions.

Authors:  Eva Ruiz; Carmen Alemán; José Alegre; Jasone Monasterio; Rosa Ma Segura; Lluis Armadans; Ana Vázquez; Teresa Soriano; Tomás Fernández de Sevilla
Journal:  Lung       Date:  2005 May-Jun       Impact factor: 2.584

5.  Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.

Authors:  Fang Fang; Ping Chen; Xin Wu; Li Yang; Xun Yang; Zhen-Xiang Xi; Bin-Wen Zhou; Xi-Kun Zhou; Zhi-Yong Qian; Bo Xiao; Yu-Quan Wei
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-15       Impact factor: 4.553

6.  The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.

Authors:  Foteini Economidou; George Margaritopoulos; Katerina M Antoniou; Nikolaos M Siafakas
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

Review 7.  Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Panagoula Kollia; Konstantinos I Gourgoulianis
Journal:  Respir Res       Date:  2006-10-17

8.  Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion.

Authors:  Kuan-Yuan Chen; Po-Hao Feng; Chih-Cheng Chang; Tzu-Tao Chen; Hsiao-Chi Chuang; Chun-Nin Lee; Chien-Ling Su; Lian-Yu Lin; Kang-Yun Lee
Journal:  Int J Gen Med       Date:  2016-06-11

9.  Immune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis.

Authors:  Diana Qama; Won-Il Choi; Kun Young Kwon
Journal:  BMC Immunol       Date:  2012-08-13       Impact factor: 3.615

10.  Pleural tuberculosis: is radiological evidence of pulmonary-associated disease related to the exacerbation of the inflammatory response?

Authors:  Leila Antonangelo; Francisco S Vargas; Juliana Puka; Márcia Seiscento; Milena M P Acencio; Lisete R Teixeira; Ricardo M Terra; Roberta K B Sales
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.